D. E. Schwartz
- Periodontics top 2%
- Pharmacology top 5%
- Antibiotics Pharmacokinetics and Efficacy 5
- Pharmacology top 5%
- Antibiotics Pharmacokinetics and Efficacy 5
-
- Malaria Research and Control 3
- Clinical Biochemistry top 10%
- Metabolism and Genetic Disorders 3
-
- Analytical Chemistry and Chromatography 4
-
- Cancer therapeutics and mechanisms 4
-
- Analytical Methods in Pharmaceuticals 4
-
- Cancer Treatment and Pharmacology 3
-
- Amino Acid Enzymes and Metabolism 2
D. E. Schwartz
28 papers receiving 767 citations
Peers
Comparison fields: 5 of 102
- Periodontics 178
- Pharmacology 122
- Pharmacology 176
- Public Health, Environmental and Occupational Health 286
- Clinical Biochemistry 44
Countries citing papers authored by D. E. Schwartz
This map shows the geographic impact of D. E. Schwartz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. E. Schwartz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. E. Schwartz more than expected).
Fields of papers citing papers by D. E. Schwartz
This network shows the impact of papers produced by D. E. Schwartz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. E. Schwartz. The network helps show where D. E. Schwartz may publish in the future.
Co-authorship network
The 25 scholars most cited alongside D. E. Schwartz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1990 | 63 | |
| 2 | 1987 | 18 | |
| 3 | 1987 | 6 | |
| 4 | Single-dose kinetics of mefloquine in Brazilian male subjects. | 1987 | 14 |
| 5 | 1987 | 16 | |
| 6 | 1987 | 50 | |
| 7 | 1982 | 58 | |
| 8 | 1981 | 20 | |
| 9 | Kinetic studies of mefloquine and of one of its metabolites, Ro 21-5104, in the dog and in man. | 1980 | 26 |
| 10 | Quantitative determination of the antimalarial drug mefloquine and of its main metabolite in plasma by direct densitometric measurement on thin-layer chromatographic plates. | 1980 | 2 |
| 11 | 1979 | 39 | |
| 12 | Pharmacokinetic and metabolic studies of the decarboxylase inhibitor benserazide in animals and man. | 1978 | 14 |
| 13 | 1976 | 91 | |
| 14 | 1974 | 2 | |
| 15 | 1972 | 12 | |
| 16 | Trimethoprim metabolites in rat, dog and man: qualitative and quantitative studies. | 1970 | 46 |
| 17 | 1969 | 95 | |
| 18 | 1964 | 9 | |
| 19 | 1955 | 5 | |
| 20 | 1954 | 1 |
About D. E. Schwartz
D. E. Schwartz is a scholar working on Clinical Biochemistry, Analytical Chemistry, Periodontics, Biochemistry and Pharmacology, having authored 28 papers that have together received 872 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (5 papers), Analytical Chemistry and Chromatography (4 papers), Cancer therapeutics and mechanisms (4 papers), Analytical Methods in Pharmaceuticals (4 papers), Metabolism and Genetic Disorders (3 papers), Cancer Treatment and Pharmacology (3 papers), Malaria Research and Control (3 papers) and Amino Acid Enzymes and Metabolism (2 papers). The work is most often cited by research in Periodontics (178 citations), Pharmacology (122 citations), Pharmacology (176 citations), Public Health, Environmental and Occupational Health (286 citations) and Clinical Biochemistry (44 citations). D. E. Schwartz has collaborated with scholars based in Switzerland, United States and Zambia. Frequent co-authors include F Jeunet, Bernard J. Moncla, K Dix, Robert E. Weinfeld, Shiro Watanabe, Bernard A. Koechlin, Walter Vetter, J. Rieder, J Raaflaub and D Richard-Lenoble. Their work appears in journals such as Chemotherapy, Journal of Clinical Microbiology, Biochemical Pharmacology, Cellular and Molecular Life Sciences and Journal of the American Chemical Society.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.